ImunonIMNN

Imunon Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With Imnn-001 Imunon宣布，使用Imnn-001治疗新诊断的爱文思控股晚期卵巢癌患者，综合生存期增长了11.1个月。